PERSERIS KIT Drug Patent Profile

Which patents cover Perseris Kit, and what generic alternatives are available?

Perseris Kit is a drug marketed by Indivior and is included in one NDA. There are ten patents protecting this drug.

The generic ingredient in PERSERIS KIT is risperidone. Forty-one suppliers are listed for this compound. Additional details are available on the risperidone profile page.

DrugPatentWatch^® Litigation and Generic Entry Outlook for Perseris Kit

A generic version of PERSERIS KIT was approved as risperidone by RISING on October 8^th, 2008.

Summary for PERSERIS KIT

US Patents:	10
Applicants:	1
NDAs:	1
Patent Litigation and PTAB cases:	See patent lawsuits and PTAB cases for PERSERIS KIT

US Patents and Regulatory Information for PERSERIS KIT

PERSERIS KIT is protected by ten US patents.

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Indivior	PERSERIS KIT	risperidone	FOR SUSPENSION, EXTENDED RELEASE;SUBCUTANEOUS	210655-001	Jul 27, 2018		DISCN	Yes	No	9,186,413
Indivior	PERSERIS KIT	risperidone	FOR SUSPENSION, EXTENDED RELEASE;SUBCUTANEOUS	210655-002	Jul 27, 2018		DISCN	Yes	No	9,597,402		Y
Indivior	PERSERIS KIT	risperidone	FOR SUSPENSION, EXTENDED RELEASE;SUBCUTANEOUS	210655-001	Jul 27, 2018		DISCN	Yes	No	11,013,809		Y
Indivior	PERSERIS KIT	risperidone	FOR SUSPENSION, EXTENDED RELEASE;SUBCUTANEOUS	210655-001	Jul 27, 2018		DISCN	Yes	No	10,376,590
Indivior	PERSERIS KIT	risperidone	FOR SUSPENSION, EXTENDED RELEASE;SUBCUTANEOUS	210655-002	Jul 27, 2018		DISCN	Yes	No	10,406,160		Y
Indivior	PERSERIS KIT	risperidone	FOR SUSPENSION, EXTENDED RELEASE;SUBCUTANEOUS	210655-002	Jul 27, 2018		DISCN	Yes	No	9,180,197		Y
Indivior	PERSERIS KIT	risperidone	FOR SUSPENSION, EXTENDED RELEASE;SUBCUTANEOUS	210655-001	Jul 27, 2018		DISCN	Yes	No	10,010,612		Y

International Patents for PERSERIS KIT

See the table below for patents covering PERSERIS KIT around the world.

Country	Patent Number	Title	Estimated Expiration
Australia	2008262545	Sustained delivery formulations of risperidone compounds
Brazil	PI0811319	COMPOSIÇÃO FLUIDA, MÉTODO DE FORMAÇÃO DE UMA COMPOSIÇÃO FLUIDA, IMPLANTE BIODEGRÁDAVEL FORMADO IN SITU, MÉTODO DE FORMAÇÃO DE UM IMPLANTE BIODEGRADÁVEL IN SITU, KIT, IMPLANTE E MÉTODO DE TRATAENTO
Canada	2687979	FORMULATIONS D'ADMINISTRATION PROLONGEE DE COMPOSES DE RISPERIDONE (SUSTAINED DELIVERY FORMULATIONS OF RISPERIDONE COMPOUNDS)
China	101801415	Sustained delivery formulations of risperidone compounds
European Patent Office	2152315	FORMULATIONS D'ADMINISTRATION PROLONGÉE DE COMPOSÉS DE RISPÉRIDONE (SUSTAINED DELIVERY FORMULATIONS OF RISPERIDONE COMPOUNDS)
European Patent Office	2907524	Formulations à libération prolongée de composés de rispéridone (Sustained delivery formulations of risperidone compounds)
Spain	2562878

Supplementary Protection Certificates for PERSERIS KIT

Patent Number	Supplementary Protection Certificate	SPC Country	SPC Expiration	SPC Description
0196132	94C0008	Belgium		PRODUCT NAME: RISPERIDONE; NAT REG.: 2 S 414 F 3 19940527; FIRST REG.: GB 0242/0186 19921208